Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by VancouverPigon Nov 22, 2017 7:35pm
88 Views
Post# 27015697

Withheld vote Information-From the CCGG

Withheld vote Information-From the CCGGJust to be clear, this is from the Canadian Coalition for Good Governance. this might better explain withheld votes and how they should be handled:

Currently, director elections under the Canadian legal regime is based on a "plurality system" where shareholders vote either "for" a director or "withhold" their vote (i.e. do not vote). In a plurality system, withhold votes do not count and technically a director needs only one "for" vote to be elected to the board.

CCGG recommends that the boards of all Canadian issuers adopt a majority voting policy.

The adoption of majority voting is a three-step process:

  1. List individual directors on the Registered Form of Proxy or the Voting Instruction form.
  2. The Board adopts an internal policy which states that for any director receiving 50% + 1 withheld votes, those votes would be considered votes "against" the director. We have collected some samples of how companies have communicated a majority voting policy to its shareholders.
  3. Once a resignation is submitted, the Corporate Governance Committee (or equivalent) reviews any extra circumstances surrounding the voting results and makes a decision whether or not to accept the resignation. The Committee's decision is made public.
Signed: VancouverPig sants his votes to count not matter "For" or "Withheld" I paid my money to vote, what are the Execs afraid of?
Bullboard Posts